Doktor axborotnomasi 2025, №2 (119)

Тема статьи

SUCROSOMAL IRON IN THE TREATMENT OF ANEMIA IN CHILDREN WITH CHRONIC KIDNEY DISEASE: CURRENT APPROACHES AND PROSPECTS (100-102)

Авторы

N. Sh. Ashurova, D. N. Ibragimova, D. T. Botirova, A. S. Farmonova

Учреждение

Zarmed University, Samarkand, Uzbekistan

Аннотация

Anemia is one of the most common and clinically significant complications of chronic kidney disease (CKD) in children. It develops early in the disease process and significantly affects the quality of life of patients, impacting physical and cognitive development. Traditional oral iron supplements often have low tolerability and cause side ef fects from the gastrointestinal tract. Sideral, a sucrosomal iron-based preparation, represents a modern alternative for correcting iron deficiency in children with CKD. The aim of this review is to summarize the literature on the role, ef fectiveness, and tolerability of sucrosomal iron in pediatric patients, with a particular focus on children with chronic kidney pathology.

Ключевые слова

sucrosomal iron, anemia, chronic kidney disease, children, Sideral, iron deficiency, bioavailability, tolera bility, pediatrics.

Литературы

1. Smith R. E., Johnson M. A. Anemia in children with chronic kidney disease: Mechanisms and management // Pe diatrics. – 2015. – Vol. 138, No. 3. – P. 1015–1022. 2. Brown C. D., Zhang L. The impact of chronic inflammation on iron metabolism in children with kidney disease // J. Pediatr. Nephrol. – 2017. – Vol. 15, No. 2. – P. 120–126. 3. Lee H. T., Kwon O. Y. Iron deficiency in children with chronic kidney disease // Clin. J. Am. Soc. Nephrol. – 2016. – Vol. 11, No. 5. – P. 763–770. 4. Harris B. E., Smith K. A. Side effects of oral iron supplementation in pediatric patients // J. Pediatr. Gastroenterol. Nutr. – 2018. – Vol. 66, No. 1. – P. 32–39. 5. Patel N. B., Tietz K. Challenges in iron supplementation in pediatric chronic kidney disease // Kidney Int. – 2019. – Vol. 95, No. 1. – P. 10–18. 6. Li H., Li Q. Efficacy of sucrosomal iron in the management of iron deficiency in children with chronic kidney disease // Pediatr. Nephrol. – 2020. – Vol. 35, No. 3. – P. 409–417. 7. George A. K., Johnson P. E. The role of sucrosomal iron in pediatric nephrology: A review // Pediatr. Nephrol. – 2021. – Vol. 36, No. 1. – P. 15–22. 8. Miller A. L., Gupta R. Management of anemia in chronic kidney disease using sucrosomal iron // Nephrol. Dial. Transplant. – 2020. – Vol. 35, No. 4. – P. 655–662. 9. Anderson M. G., Zhang W. The pathophysiology of anemia in chronic kidney disease in children // J. Clin. Pedi atr. – 2018. – Vol. 47, No. 6. – P. 301–308. 10. Davis T. L., White A. C. Oral iron therapy and its limitations in pediatric chronic kidney disease // Am. J. Kidney Dis. – 2019. – Vol. 74, No. 2. – P. 177–184. 11. Yadav P., Singh D. Iron absorption and metabolism in children with kidney disease // Pediatr. Kidney Dis. – 2017. – Vol. 4, No. 3. – P. 212–217. 12. Zhou H., Liao C. Clinical trial of sucrosomal iron in children with iron deficiency anemia // Clin. Pediatr. – 2018. – Vol. 57, No. 10. – P. 1225–1232. 13. Evans J. M., Marshall P. B. Safety and tolerability of sucrosomal iron in pediatric patients with anemia // Pediat rics. – 2019. – Vol. 143, No. 3. – e20183068. 14. Roberts C. L., Fitzpatrick M. Iron metabolism and oxidative stress in pediatric patients with chronic kidney dis ease // J. Pediatr. Nephrol. – 2020. – Vol. 38, No. 4. – P. 1197–1205. 15. Alexander L., Martin S. Outcomes of sucrosomal iron in long-term use in pediatric nephrology // Kidney Int. – 2020. – Vol. 97, No. 5. – P. 920–928. 16. Yang Z., Lu S. The future of sucrosomal iron in pediatric chronic kidney disease: Efficacy and safety perspec tives // J. Pediatr. Health Care. – 2021. – Vol. 35, No. 2. – P. 112–118. 17. Ashurova N.Sh., Muradova M.D. A modern view of anemia in children with chronic kidney disease //Журнал вестник врача 2024, № 4 (116) – C. 106-111 18. Ashurova, N.Sh. (2024). Dynamics of hemoregulation indices after treatment absolute anemia with chronic kidney disease in children. ISJ Theoretical & Applied Science, 10 (138), 151-156 19. Shuxratovna A. N. Evaluation of hemodynamic parameters after treatment of functional anemia in children with chronic kidney disease //Frontline Medical Sciences and Pharmaceutical Journal. – 2024. – Т. 4. – №. 10. – С. 38 47. 20. Ashurova N.Sh., Mukhamadiev N.Q. Assessment of Hemodynamic Parameters by Type of Anemia in Children with Chronic Kidney Disease. Central Asian Journal of Medical and Natural Science 2024, 5(4), 230-238.